Bacteriostatic and Bactericidal Activities of Tigecycline against Coxiella burnetii and Comparison with Those of Six Other Antibiotics

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

The present article is a study of the in vitro susceptibility of eight Greek Coxiella burnetii isolates, derived from patients with acute Q fever, and two reference strains of Coxiella burnetii to tigecycline. The bacteriostatic activity of tigecycline was compared with those of six other antibiotics using a shell vial assay. The MICs of the examined antibiotics were as follows: tigecycline ranged from 0.25 to 0.5 microg/ml; doxycycline, trovafloxacin, and ofloxacin ranged from 1 to 2 microg/ml; linezolid and clarithromycin ranged from 2 to 4 microg/ml; and ciprofloxacin ranged from 4 to 8 microg/ml. Tigecycline was effective in inhibiting the infection of Vero cells by C. burnetii. No bactericidal activity was observed against C. burnetii at 4 microg/ml.

Knowledge Graph

Similar Paper

Bacteriostatic and Bactericidal Activities of Tigecycline against Coxiella burnetii and Comparison with Those of Six Other Antibiotics
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activities of Tigecycline and Eight Other Antimicrobials against Different Nocardia Species Identified by Molecular Methods
Antimicrobial Agents and Chemotherapy 2007.0
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activities of Tigecycline and 10 Other Antimicrobials against Nonpigmented Rapidly Growing Mycobacteria
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activities of Various Antimicrobials Alone and in Combination with Tigecycline against Carbapenem-Intermediate or -Resistant Acinetobacter baumannii
Antimicrobial Agents and Chemotherapy 2007.0
In Vitro Activity of Tigecycline against Multidrug-Resistant Acinetobacter baumannii and Selection of Tigecycline-Amikacin Synergy
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activities of Tigecycline against Clinical Isolates of Aeromonas , Vibrio , and Salmonella Species in Taiwan
Antimicrobial Agents and Chemotherapy 2008.0
Ineffectiveness of Tigecycline against Persistent Borrelia burgdorferi
Antimicrobial Agents and Chemotherapy 2010.0
Antimalarial Activity of Tigecycline, a Novel Glycylcycline Antibiotic
Antimicrobial Agents and Chemotherapy 2009.0
Controlled Trial of a 5-Day Course of Telithromycin versus Doxycycline for Treatment of Mild to Moderate Scrub Typhus
Antimicrobial Agents and Chemotherapy 2007.0